Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Urinary glycosaminoglycans in rats treated with low doses of ochratoxin A (CROSBI ID 82136)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Juretić, Dubravka ; Bobetić-Vranić, Tanja ; Čepelak, Ivana ; Pepeljnjak, Stjepan Urinary glycosaminoglycans in rats treated with low doses of ochratoxin A // Acta pharmaceutica, 48 (1998), 1; 47-53-x

Podaci o odgovornosti

Juretić, Dubravka ; Bobetić-Vranić, Tanja ; Čepelak, Ivana ; Pepeljnjak, Stjepan

engleski

Urinary glycosaminoglycans in rats treated with low doses of ochratoxin A

Ochratoxin A (OTA) is a mycotoxin produced by Aspergillus ochraceus and is a natural contaminant of moldy food. An increased presence of this toxin has been found in various foodstuffs in the area characterized by the occurence of endemic nephropathy. We therefore have decided to clarify the following questions: whether the presence of OTA in a relatively low concentration taken in food over a prolonged period of time also leads to toxic alteration in rats similar to subclinical phase of endemic nephropathy and what is significance of urinary glycosaminoglycans and chondroitin sulfate/heparan sulfate ratio as a diagnostic parameters. We conclude that treatments of rats with low doses of ochratoxin A resulted in kidney impairment with no differences in urinary glycosaminoglycans. Therefore, urinary glycosaminoglycans are not enough sensitive and specific diagnostic parameters of kidney alterations induced with low doses of Ochratoxin A.

ochratoxin A; endemic nephropathy; glycosaminoglycans

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

48 (1)

1998.

47-53-x

objavljeno

1330-0075

Povezanost rada

Temeljne medicinske znanosti, Javno zdravstvo i zdravstvena zaštita

Indeksiranost